Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -110.78M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 23,600
Avg Vol 30,360
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 64%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
Latest News on HUMAW
Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 12:21 PM EST - 3 months ago

Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript


Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Aug 12, 2025, 1:20 PM EDT - 7 months ago

Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress


Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 10:00 AM EDT - 7 months ago

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript


Humacyte: Revenue Ramp From Symvess Incoming

Jun 11, 2025, 9:05 AM EDT - 9 months ago

Humacyte: Revenue Ramp From Symvess Incoming


Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 2:29 PM EDT - 10 months ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript


Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Mar 28, 2025, 1:48 PM EDT - 11 months ago

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript


Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 1 year ago

Trestle Bio Announces Research Collaboration with Humacyte